Last 47 quarters of trend data · Healthcare · Medical - Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -17.34 | 10.65 | 39.73 | 26.99 | 26.72 | 22.51 | — | 11.35 | 21.89 | 45.68 | — | 43.12 | — | 642.88 | 77.82 | 446.46 | — | 52.06 | 340.96 | — | — |
| — | -52.7% | — | +137.8% | +22.1% | -50.7% | — | -73.7% | — | -92.9% | — | -90.3% | — | +1134.9% | -77.2% | — | — | — | — | — | — | |
| P/S Ratio | 3.05 | 2.96 | 2.45 | 2.32 | 2.02 | 1.75 | 1.69 | 1.97 | 2.25 | 2.35 | 2.56 | 2.26 | 2.50 | 2.36 | 2.23 | 2.72 | 2.69 | 3.32 | 4.61 | 4.31 | 4.03 |
| — | +69.6% | +45.4% | +18.1% | -10.4% | -25.6% | -34.1% | -13.1% | -9.7% | -0.6% | +14.9% | -16.7% | -7.2% | -28.9% | -51.7% | -37.0% | -33.3% | -14.5% | +27.2% | +44.5% | +76.1% | |
| P/B Ratio | 3.50 | 3.49 | 2.93 | 2.79 | 2.50 | 2.19 | 2.07 | 1.92 | 2.19 | 2.41 | 2.47 | 2.20 | 2.33 | 2.24 | 1.91 | 2.47 | 2.37 | 2.64 | 3.43 | 3.60 | 3.11 |
| — | +59.2% | +41.9% | +45.6% | +14.1% | -8.9% | -16.4% | -12.7% | -6.1% | +7.6% | +29.2% | -11.1% | -1.7% | -15.1% | -44.2% | -31.3% | -23.9% | -33.3% | +1.8% | +24.1% | +91.1% | |
| P/FCF | 24.47 | 33.03 | 959.23 | 16.70 | 11.63 | 12.89 | 40.56 | 9.27 | 21.83 | 23.98 | 210.77 | 17.11 | 75.80 | — | 44.92 | 78.07 | 22.96 | — | 53.78 | 44.99 | 49.38 |
| — | +156.3% | +2265.0% | +80.1% | -46.7% | -46.3% | -80.8% | -45.8% | -71.2% | — | +369.2% | -78.1% | +230.2% | — | -16.5% | +73.5% | -53.5% | — | -32.6% | +70.0% | — | |
| EV / EBITDA | 16.89 | 43.43 | 12.35 | 18.70 | 10.31 | 8.49 | 8.20 | 14.02 | 16.42 | 15.92 | 28.83 | — | 41.48 | 22.18 | 47.72 | 28.82 | — | 18.93 | 46.32 | 31.18 | 32.25 |
| — | +411.3% | +50.5% | +33.4% | -37.2% | -46.6% | -71.5% | — | -60.4% | -28.2% | -39.6% | — | — | +17.1% | +3.0% | -7.6% | — | — | -67.6% | — | -10.5% | |
| EV / EBIT | 20.44 | 43.43 | 23.96 | 16.82 | 15.26 | 12.90 | — | 9.62 | 13.27 | 22.50 | — | — | 62.32 | 35.68 | 25.93 | 42.45 | — | 26.06 | 83.77 | — | — |
| — | +236.8% | — | +74.7% | +15.0% | -42.7% | — | — | -78.7% | -36.9% | — | — | — | +36.9% | -69.0% | — | — | — | -74.4% | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.7% | 70.1% | 67.6% | 66.4% | 68.4% | 67.8% | 69.7% | 68.2% | 70.8% | 67.4% | 70.3% | 61.3% | 70.5% | 69.8% | 66.1% | 66.8% | 67.7% | 72.5% | 70.1% | 73.1% | 66.6% |
| — | +3.4% | -3.0% | -2.5% | -3.3% | +0.5% | -0.9% | +11.2% | +0.4% | -3.4% | +6.4% | -8.2% | +4.2% | -3.7% | -5.8% | -8.7% | +1.6% | +11.4% | +6.3% | +30.4% | +12.0% | |
| Operating Margin | 14.4% | 12.7% | 14.4% | 11.8% | 15.1% | 15.4% | 15.3% | 11.5% | 11.2% | 12.6% | 5.5% | -28.4% | 1.6% | 5.9% | -0.9% | 5.1% | -52.2% | 12.5% | 4.0% | 7.6% | 6.5% |
| — | -17.5% | -6.1% | +2.7% | +34.8% | +21.9% | +178.5% | +140.5% | +618.6% | +113.2% | +719.6% | -658.6% | +103.0% | -52.7% | -122.5% | -33.5% | -905.6% | +191.1% | +272.0% | +108.2% | +581.3% | |
| Net Margin | -17.5% | 27.8% | 6.2% | 8.6% | 7.5% | 7.7% | -103.3% | 17.4% | 10.4% | 5.1% | -14.2% | 5.3% | -2.6% | 0.4% | 2.8% | 0.6% | -42.5% | 6.5% | 1.2% | -3.2% | -17.2% |
| — | +260.9% | +106.0% | -50.7% | -27.7% | +50.3% | -626.4% | +229.6% | +505.0% | +1204.6% | -608.3% | +771.8% | +94.0% | -93.9% | +124.5% | +119.1% | -147.7% | +130.3% | +110.0% | +97.0% | -178.8% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -19.2% | 8.6% | 1.8% | 2.6% | 2.4% | 2.5% | -27.8% | 4.2% | 2.6% | 1.3% | -3.4% | 1.3% | -0.6% | 0.1% | 0.6% | 0.1% | -8.8% | 1.3% | 0.2% | -0.7% | -3.7% |
| — | +240.0% | +106.7% | -38.4% | -9.0% | +90.0% | -728.3% | +225.5% | +535.0% | +1316.3% | -654.5% | +825.2% | +93.3% | -92.7% | +161.6% | +121.5% | -139.4% | +123.8% | +108.2% | +97.2% | -235.4% | |
| ROA | -9.5% | 4.2% | 0.9% | 1.2% | 1.1% | 1.1% | -12.9% | 2.2% | 1.3% | 0.7% | -1.7% | 0.7% | -0.3% | 0.0% | 0.3% | 0.1% | -4.7% | 0.7% | 0.1% | -0.4% | -1.9% |
| — | +292.7% | +106.7% | -46.2% | -20.1% | +61.3% | -653.3% | +223.7% | +522.8% | +1235.1% | -634.2% | +831.8% | +93.4% | -92.8% | +147.8% | +119.0% | -149.8% | +129.2% | +110.0% | +96.6% | -221.2% | |
| ROIC | 11.5% | 3.4% | 3.8% | 3.1% | 4.0% | 4.1% | 2.9% | 1.7% | 1.7% | 1.9% | 0.8% | -4.0% | 0.2% | 1.0% | -0.1% | 0.7% | -7.6% | 1.7% | 0.5% | 1.1% | 0.9% |
| — | -16.3% | +33.5% | +81.6% | +144.0% | +116.0% | +281.5% | +142.8% | +627.1% | +90.2% | +711.9% | -639.2% | +103.0% | -42.8% | -123.5% | -32.3% | -979.7% | +194.6% | +289.2% | +110.0% | +746.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.39 | 0.27 | 0.28 | 0.39 | 0.42 | 0.43 | 0.66 | 0.51 | 0.52 | 0.55 | 0.55 | 0.50 | 0.51 | 0.50 | 0.47 | 0.48 | 0.50 | 0.40 | 0.39 | 0.22 | 0.22 |
| — | -38.2% | -57.9% | -23.1% | -19.0% | -21.1% | +18.3% | +2.3% | +2.4% | +8.4% | +17.0% | +4.3% | +0.6% | +26.9% | +21.8% | +117.0% | +128.9% | -42.5% | -41.8% | -65.4% | -57.9% | |
| Debt / EBITDA | 1.96 | 13.69 | 4.94 | 11.10 | 7.34 | 6.97 | 10.71 | 13.64 | 13.95 | 12.92 | 23.03 | — | 31.77 | 19.31 | 46.09 | 19.95 | — | 11.06 | 20.72 | 7.55 | 8.89 |
| — | +96.4% | -53.9% | -18.7% | -47.3% | -46.0% | -53.5% | — | -56.1% | -33.1% | -50.0% | — | — | +74.7% | +122.5% | +164.4% | — | — | -79.4% | — | -76.6% | |
| Current Ratio | 1.36 | 1.45 | 1.33 | 1.36 | 1.33 | 1.29 | 1.58 | 2.87 | 3.37 | 3.45 | 3.17 | 2.95 | 3.23 | 3.27 | 2.86 | 2.98 | 2.96 | 2.93 | 2.63 | 0.97 | 0.98 |
| — | +12.5% | -15.8% | -52.6% | -60.7% | -62.7% | -50.2% | -2.6% | +4.4% | +5.7% | +11.1% | -1.0% | +9.3% | +11.7% | +8.6% | +205.8% | +201.1% | +153.9% | +12.4% | -57.5% | -58.9% | |
| Quick Ratio | 1.16 | 1.21 | 1.11 | 1.16 | 1.12 | 1.09 | 1.37 | 2.50 | 2.87 | 2.94 | 2.71 | 2.51 | 2.68 | 2.73 | 2.41 | 2.54 | 2.53 | 2.47 | 2.26 | 0.82 | 0.79 |
| — | +10.7% | -18.8% | -53.6% | -60.9% | -63.0% | -49.3% | -0.4% | +7.0% | +8.0% | +12.5% | -1.4% | +5.9% | +10.2% | +6.6% | +209.3% | +219.0% | +154.6% | +17.7% | -57.1% | -54.8% | |
| Interest Coverage | -3.48 | 3.57 | 4.21 | 2.40 | 4.12 | 3.71 | -19.65 | 4.58 | 3.80 | 2.39 | -1.15 | -5.04 | 0.87 | 1.36 | 1.73 | 1.48 | -7.38 | 2.32 | 1.71 | -0.01 | -2.66 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying LIVN stock.
LivaNova PLC's current P/E is -17.3x. The average P/E over the last 4 quarters is 26.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
LivaNova PLC's current operating margin is 14.4%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking LivaNova PLC's business trajectory between earnings reports.